Skip to main content
. 2023 Feb 24;14(1):2178203. doi: 10.1080/20008066.2023.2178203

Table 1.

Study characteristics.

First Author, Country, Setting N Age (Range, M (SD)) Gender (M/F) Military Status PTSD/GD diagnosis Design, Context, Intervention, Control/Comparison, Duration Time Point ACT Elements Reported Outcomes
Shirk et al. (2022), US, VA, mental health outpatient care 3 46–57 3/0 100% army, veterans. Persian Gulf and Vietnam era(s) Not reported Case series/feasibility study, group setting, manualised treatment, 9 weekly sessions, homework, duration 3 months. Pre-test, post-test Adapted MBRP Reduced gambling behaviour (instances), cravings (impulsivity), emotional dysregulation
Instances reduced from 21x – 3x per month across participants. Collectively impulsivity decreased from M = 50.7 to M = 44.3 and emotional dysregulation reduced from M = 56.3 to M = 40.0
Reyes et al. (2022), US, technology based 23 M 31.22 (5.53) 0/23 Veterans, Iraq/Afghanistan era PTSD – DSM-5/ PCL-5 Quasi experiment, app-based delivery, daily/weekly activity engagement prompts, duration 1 month. Pre-test, during, post-test Mindfulness, ACT Global PTSD scores, experiential avoidance, mindfulness
PTSD – T1 to T2 M-11.61 (SD 12.71) and T3 M-27.78 (SD 14.22), p < .001.
Experiential avoidance significantly improved at T3 M-7.71 (SD 6.97), p < .001
Mindfulness and PTSD symptoms were negatively significantly corelated (r = −.632)
Ramirez et al. (2021), US, trauma focused outpatient care 311 M 37.6 (8.06) 193/118 Active duty PTSD – DSM-5/ PCL-5 Quasi experiment, group setting with 2 (60-90 min) one-to-one sessions, homework, duration 6 weeks. Pre-test, during (weekly) Exposure therapy combined with ACT Global PTSD scores; PDS-5 and PCL-5, experiential avoidance.
PTSD – PDS-5: M = −20.47 (SD 16.13), p < .000, d = 1.33. PCL-5: M = −18.12 (SD15.49), d = 1.19. 25.4%−28.3% (were below the PTSD clinical cut-off)
Avoidance significantly reduced (M = −6.86, SD 9.30, d = 0.88)
Smith et al. (2021), US, technology based 1 Late 20s 1/0 Veteran PTSD – DSM-5/ PCL-5 Single case study; individual ‘telehealth’ video conferencing setting, manualised treatment, 19 60-minute sessions, duration 5 months. Pre-test, during, post-test, 1 month follow up ACT Global PTSD, experiential avoidance.
PTSD reduced by 79%. Avoidance reduced (unreported)
Reyes et al. (2020a), US, VA, technology-based 23 M 31.22 (5.53) 0/23 Veterans, Iraq/Afghanistan era PTSD – DSM-5/ PCL-5 Feasibility study, app-based delivery, daily/weekly activity engagement prompts, duration 4 weeks. Pre-test, during and post-test; 4 weeks Mindfulness, ACT Global PTSD scores and app usability.
PTSD reduced (−12.39, p < .001). App usability score – ‘excellent’ M 85.11 (SD 19.44)
Reyes et al. (2020b), US, technology-based 9 M 31.44 (not reported) 3/6 Veterans Not reported Feasibility study, mixed methods, daily/weekly activity app engagement prompts, in-person interviews conducted at the intention conclusion, duration 2 weeks. Pre-test, during and post-test Mindfulness, ACT Global PTSD scores and app satisfaction.
PTSD – deceased significantly (F = 5.08, p = .027). App satisfaction scores – ‘good’ (M 72.75)
Qualitative themes elicited: instituting a sense of progression; integrating a sense of rhythm; inculcating a sense of contribution
Kelly et al. (2020), US, VA, post-service reintegration programme 1 50s 1/0 Veteran, Gulf era PTSD – DSM-5/PCL-5 and SCID-5 Single case study, manualised treatment, 12 50-minute sessions, homework, duration 12 weeks. Pre-test, during, post-test, 3 months follow up Social support focused ACT (ACT-SS) Global PTSD scores and negative thoughts
PTSD – mean reduced 12.5%
Cluster of negative thoughts reduced but unreported
Dindo et al. (2020), US, VA, polytrauma clinical care 42   42/0 Veterans PTSD – DSM-IV/SCID-I Pilot and follow-up RCT (ACT versus TAU), development and evaluation study, manualised treatment, homework, group-based, duration 3 months.
TAU = psychoeducation
Pre-test, post-test, pilot measured at 2 weeks and 3 months, RCT measured at 3 months ACT Global PTSD scores, psychological flexibility
PTSD and psychological flexibility saw non-signification reduction
Gobin et al. (2019), US, VA, multi-site clinical study 117 M 35.75 (8.1) 94/23 Veterans, Iraq/Afghanistan era PTSD – DSM-IV/PCL-M Secondary data study related to RTC by Lang et al. (2017) (see below). Data scrutinised for gender differences in intervention outcome. Pre-test, post-test, 6, 9, 12 months follow up Mindfulness, ACT Global PTSD scores
Gender difference over time (F(2,109.15) = 412, p < .05). Women had significant result (F(1,19.47) = 11.88, p < .01)
PTSD – greater effect with ACT versus PCT (d = 1.20)
Wharton et al. (2019), US, VA, PTSD clinical care 21 M 54.5 (all >50) 21/0 Veterans, Vietnam era PTSD – DSM-IV/ PCL-M Pilot, quasi experiment, group therapy versus individual therapy, 12 weekly 60-minute sessions (individual therapy) or 90-minute session (group therapy), manualised ACT, duration 12 weeks. Pre-test, post-test, 3 months follow up ACT Global PTSD scores, experiential avoidance, hyperarousal
PTSD – group therapy (t(9) = 2.67, p < .05,g = 0.69). Individual therapy (t(7) = 2.42, p < .05, g = 1.24)
Avoidance – group therapy (t(8) = 2.92, p < .05, g = 0.851), individual therapy (t(7) = 3.40, p < .05, g = 1.04)
Hyperarousal – individual therapy (t(7) = 2.58, p < .05, g = 1.184)
Meyer et al. (2018), US, VA 43 M 45.26 (6.6) 38/5 Veterans PTSD – DSM-5/PCL-5 and CAPS-5 Pilot, quasi experiment, 12 weekly sessions, manualised treatment, one-to-one setting, homework, duration 3 months. Pre-test, post-test, 3 months follow up ACT Global PTSD, experiential avoidance
PTSD – reduced (M −12.76, d = 0.96) at intervention end and at 3-month follow-up (M −12.34, d = 0.88)
Experiential avoidance reduced (M −6.8, d = 0.62).
Lang et al. (2017), US, VA, multi-site clinical study 160 M 34 (8) 128/332 Veterans, Iraq/Afghanistan era PTSD – DSM-IV/PCL-M RCT of ACT versus PCT (person-centred treatment), manualised treatment, 12 60-minute one-to-one sessions, homework, duration 12 weeks. Pre-test, post-test, 6, 9, 12 months follow up ACT Global PTSD scores.
PTSD – reduced overall (d = 0.78) but no between condition differences
Shipherd et al. (2016), US, VA, mandatory post-deployment assessment/re-assessment 1524 M 28.65 (6.72) 1372/152 Activity duty PTSD – DSM-IV/PCL-C NR RCT comparing 4 conditions (TAU; PIT (psychoeducation)); ‘PIT + change’ (PIT + CBT); ‘PIT + acceptance’ (PIT + ACT), workshop/group face-to-face setting, 1 single session 50-60 min for ‘change’ or ‘acceptance’ or 20-30 min for PIT, duration 1 session. Pre-test, post-test, 1 month follow up Acceptance-based Global PTSD scores
PTSD – ‘reset’ condition outperformed TAU (p = .047, d = 0.09) and PIT (p = .021, d = 0.14). No significant difference between ‘reset’ and ‘control’
Blevins et al. (2011), US, military-base Guardsmen training 144 M 30 (9.70), control M 32.4 (8.70) 134/10 Guardsmen, Iraq/Afghanistan era PTSD – DSM-IV/PCL Quasi experiment, control versus ACT, workshop/group setting; 1 single two-hour session, duration 2-hours. Pre-test, post-test, intervention group 2 months follow up, control group 4 months follow up Acceptance-based Global PTSD scores
PTSD – reduced over time (M-4.561 (CI −8.05, −1.07), p < .05) but no significant between-group difference

Note: US, United States; VA, Veteran Affairs Administration; M (SD), mean (standard deviation); OR, odds ratio; CI, confidence interval; RCT, randomised control trial; TAU, treatment as usual; ACT, acceptance and commitment therapy; ACT-SS, acceptance and commitment therapy for social support; PIT, psychoeducation; PCT, patient centred treatment; MBRP, mindfulness-based relapse prevention; DSM, Diagnostic and Statistical Manual; PTSD, post traumatic stress disorder; GD, gambling disorder; PCL, Patient Checklist; PCL-M Patient Checklist Military; PCL-C, Patient Checklist Civilian; PDS, post traumatic diagnostic scale; PSSI, post traumatic stress disorder symptom scale; SCID, I/5 – structured clinical interview for Axis I disorders/DSM; CAPS-5, clinically administered PTSD scale for DSM-5.